November 9-11, 2020 | Virtual Conference

Speakers

Zhi Chen, MS, RAC

Associate Director of Regulatory Affairs
Glenmark Pharmaceuticals Inc., USA

Zhi Chen is Associate Director of Regulatory Affairs, Glenmark Pharmaceuticals Inc., USA. His responsibility includes both drug product and API at Glenmark. He served at Prinston Pharmaceutical, Inc., Hoffmann La-Roche Inc., and Bayer Corporation for various positions previously.
His expertise includes regulatory affairs of NDA/ANDA/DMF, drug development, chemical synthesis, API manufacture, and DMPK. He graduated with a MS degree in organic chemistry from Baylor University and BS degree in chemistry from Nankai University.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Skip to content